These results reflect regulation of mGluR5 in the human hippocampal region during development, and point to an early-development role for this receptor in Down syndrome astrocytes, as well as a possible role in the pathophysiology of markers linked to Alzheimer’s disease (Iyer et al., 2014). This evidence concerns the gene GRM5 and Alzheimer disease.